Anti-PRD12/ PRDM12/ HSAN8 functional antibody

Anti-PRD12/ PRDM12/ HSAN8 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to PRDM12/PRDM12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1494-Ab-1/ GM-Tg-hg-SE1494-Ab-2Anti-Human PRDM12 monoclonal antibodyHuman
GM-Tg-rg-SE1494-Ab-1/ GM-Tg-rg-SE1494-Ab-2Anti-Rat PRDM12 monoclonal antibodyRat
GM-Tg-mg-SE1494-Ab-1/ GM-Tg-mg-SE1494-Ab-2Anti-Mouse PRDM12 monoclonal antibodyMouse
GM-Tg-cynog-SE1494-Ab-1/ GM-Tg-cynog-SE1494-Ab-2Anti-Cynomolgus/ Rhesus macaque PRDM12 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1494-Ab-1/ GM-Tg-felg-SE1494-Ab-2Anti-Feline PRDM12 monoclonal antibodyFeline
GM-Tg-cang-SE1494-Ab-1/ GM-Tg-cang-SE1494-Ab-2Anti-Canine PRDM12 monoclonal antibodyCanine
GM-Tg-bovg-SE1494-Ab-1/ GM-Tg-bovg-SE1494-Ab-2Anti-Bovine PRDM12 monoclonal antibodyBovine
GM-Tg-equg-SE1494-Ab-1/ GM-Tg-equg-SE1494-Ab-2Anti-Equine PRDM12 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1494-Ab-1/ GM-Tg-hg-SE1494-Ab-2; GM-Tg-rg-SE1494-Ab-1/ GM-Tg-rg-SE1494-Ab-2;
GM-Tg-mg-SE1494-Ab-1/ GM-Tg-mg-SE1494-Ab-2; GM-Tg-cynog-SE1494-Ab-1/ GM-Tg-cynog-SE1494-Ab-2;
GM-Tg-felg-SE1494-Ab-1/ GM-Tg-felg-SE1494-Ab-2; GM-Tg-cang-SE1494-Ab-1/ GM-Tg-cang-SE1494-Ab-2;
GM-Tg-bovg-SE1494-Ab-1/ GM-Tg-bovg-SE1494-Ab-2; GM-Tg-equg-SE1494-Ab-1/ GM-Tg-equg-SE1494-Ab-2
Products NameAnti-PRDM12 monoclonal antibody
Formatmab
Target NamePRDM12
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PRDM12 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1494-Ag-1Recombinant multi-species PRD12/ PRDM12/ HSAN8 protein


    Target information

    Target IDGM-SE1494
    Target NamePRDM12
    Gene ID59335,381359,688699,716040,119873358,111557554,618320,100146306
    Gene Symbol and SynonymsGm998,HSAN8,PFM9,PRDM12
    Uniprot AccessionQ9H4Q4
    Uniprot Entry NamePRD12_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130711
    Target ClassificationN/A

    The target: PRDM12, gene name: PRDM12, also named as HSAN8, PFM9. This gene encodes a transcriptional regulator of sensory neuronal specification that plays a critical role in pain perception. The encoded protein contains an N-terminal PRDI-BF1 and RIZ homology (PR) domain, a SET domain, and three C-terminal C2H2 zinc finger DNA-binding domains. Naturally occurring mutations in this gene are associated with congenital insensitivity to pain (CIP), and hereditary sensory and autonomic neuropathies (HSAN's) affecting peripheral sensory and autonomic neurons. Deregulation of this gene is associated with solid cancers and hematological malignancies including chronic myeloid leukaemia. [provided by RefSeq, Mar 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.